ELIAS Animal Health: Funding, Investors & Team (Sep 2026)
ELIAS Animal Health is bringing new hope to veterinarians and pet owners through their innovative approach to treating cancer in dogs. They understand that each canine patient and their cancer is unique, so they have developed a personalized treatment called ELIAS Cancer Immunotherapy (ECI™). This therapy works by using the dog's own immune system to target and destroy cancer cells with activated T cells.
ELIAS Animal Health has raised $10.0M across 1 funding round on record, the most recent a Series A of $10.0M announced in Apr 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ELIAS Animal Health Company Profile and Key Stats
Latest funding round on record: Apr 2024.
ELIAS Animal Health Funding Rounds
ELIAS Animal Health Founders and Leadership Team
Contact details for the ELIAS Animal Health team: 1 of 1 has an email address on file.
Start 14-day free trial →ELIAS Animal Health Funding Compared to Other Biotechnology Startups
ELIAS Animal Health's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ELIAS Animal Health in Biotechnology and Olathe
Companies Similar to ELIAS Animal Health
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
ELIAS Animal Health Funding FAQs
What does ELIAS Animal Health do?
ELIAS Animal Health is bringing new hope to veterinarians and pet owners through their innovative approach to treating cancer in dogs. They understand that each canine patient and their cancer is unique, so they have developed a personalized treatment called ELIAS Cancer Immunotherapy (ECI™). This therapy works by using the dog's own immune system to target and destroy cancer cells with activated T cells.
How much funding has ELIAS Animal Health raised?
ELIAS Animal Health has raised $10.0M across 1 round on record. The most recent is a Series A of $10.0M announced in Apr 2024.
When did ELIAS Animal Health last raise funding?
ELIAS Animal Health's most recent funding round on record is a Series A of $10.0M, announced in Apr 2024.
Who founded ELIAS Animal Health?
FundedIQ lists Tammie Wahaus (Founder) at ELIAS Animal Health.
Where is ELIAS Animal Health headquartered?
ELIAS Animal Health is based in Olathe, Kansas, United States.
How many employees does ELIAS Animal Health have?
ELIAS Animal Health is in the 1-10 employee band.
How does ELIAS Animal Health's funding compare to other Biotechnology startups?
ELIAS Animal Health's latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's ELIAS Animal Health Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ELIAS Animal Health is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.